Search

Search Constraints

You searched for: Author/Creator Pollyea, Daniel A.

Search Results

11. Inhibition of calcineurin combined with dasatinib has direct and indirect anti‐leukemia effects against BCR‐ABL1+ leukemia. Issue 9 (19th June 2014)

13. MDS‐associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells. Issue 1 (6th November 2020)

18. Real‐world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower‐risk myelodysplastic syndromes. (21st November 2020)

20. Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis. (June 2019)